Literature DB >> 23239045

Perspectives and potential applications of nanomedicine in breast and prostate cancer.

Yang Liu1, Metasebya Solomon, Samuel Achilefu.   

Abstract

Nanomedicine is a branch of nanotechnology that includes the development of nanostructures and nanoanalytical systems for various medical applications. Among these applications, utilization of nanotechnology in oncology has captivated the attention of many research endeavors in recent years. The rapid development of nano-oncology raises new possibilities in cancer diagnosis and treatment. It also holds great promise for realization of point-of-care, theranostics, and personalized medicine. In this article, we review advances in nano-oncology, with an emphasis on breast and prostate cancer because these organs are amenable to the translation of nanomedicine from small animals to humans. As new drugs are developed, the incorporation of nanotechnology approaches into medicinal research becomes critical. Diverse aspects of nano-oncology are discussed, including nanocarriers, targeting strategies, nanodevices, as well as nanomedical diagnostics, therapeutics, and safety. The review concludes by identifying some limitations and future perspectives of nano-oncology in breast and prostate cancer management.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 23239045     DOI: 10.1002/med.20233

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  12 in total

Review 1.  Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Authors:  William C Zamboni; Vladimir Torchilin; Anil K Patri; Jeff Hrkach; Stephen Stern; Robert Lee; Andre Nel; Nicholas J Panaro; Piotr Grodzinski
Journal:  Clin Cancer Res       Date:  2012-06-05       Impact factor: 12.531

2.  Hands-free, wireless goggles for near-infrared fluorescence and real-time image-guided surgery.

Authors:  Yang Liu; Adam Q Bauer; Walter J Akers; Gail Sudlow; Kexian Liang; Duanwen Shen; Mikhail Y Berezin; Joseph P Culver; Samuel Achilefu
Journal:  Surgery       Date:  2011-05       Impact factor: 3.982

3.  Near-infrared fluorescence goggle system with complementary metal-oxide-semiconductor imaging sensor and see-through display.

Authors:  Yang Liu; Raphael Njuguna; Thomas Matthews; Walter J Akers; Gail P Sudlow; Suman Mondal; Rui Tang; Viktor Gruev; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2013-10       Impact factor: 3.170

Review 4.  Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.

Authors:  Firas H Kobeissy; Basri Gulbakan; Ali Alawieh; Pierre Karam; Zhiqun Zhang; Joy D Guingab-Cagmat; Stefania Mondello; Weihong Tan; John Anagli; Kevin Wang
Journal:  OMICS       Date:  2014-01-10

5.  Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice.

Authors:  Ruibao Chen; Yunqi Zhao; Yan Huang; Qiuhong Yang; Xing Zeng; Wencong Jiang; Jihong Liu; J Brantley Thrasher; M Laird Forrest; Benyi Li
Journal:  Prostate       Date:  2015-01-25       Impact factor: 4.104

6.  Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.

Authors:  Tracy W Liu; Thomas D Macdonald; Cheng S Jin; Joseph M Gold; Robert G Bristow; Brian C Wilson; Gang Zheng
Journal:  ACS Nano       Date:  2013-04-05       Impact factor: 15.881

7.  Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.

Authors:  Yinbo Zhao; Dayong Lin; Fengbo Wu; Li Guo; Gu He; Liang Ouyang; Xiangrong Song; Wei Huang; Xiang Li
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

Review 8.  Active targeted drug delivery for microbes using nano-carriers.

Authors:  Yung-Sheng Lin; Ming-Yuan Lee; Chih-Hui Yang; Keng-Shiang Huang
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

9.  PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study.

Authors:  Ralph Hübner; Alexa Paretzki; Valeska von Kiedrowski; Marco Maspero; Xia Cheng; Güllü Davarci; Diana Braun; Helen Damerow; Benedikt Judmann; Vasileios Filippou; Clelia Dallanoce; Ralf Schirrmacher; Björn Wängler; Carmen Wängler
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-02

Review 10.  Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment.

Authors:  Marco Cordani; Raffaele Strippoli; Álvaro Somoza
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.